PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.\', \'Department of Medicine, Surgery and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy; U.O. Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale, Azienda Socio-Sanitaria Territoriale di Cremona, Cremona, Italy.\', \'U.O. Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale, Azienda Socio-Sanitaria Territoriale di Cremona, Cremona, Italy.\', \'Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.\', \'Department of Management, University of Turin, Turin, Italy; Centre for Research on Health and Social Care Management (CeRGAS), SDA Bocconi School of Management, Milan, Italy.\', \'Division of Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy.\', \'Scientific Direction, IEO, European Institute of Oncology IRCCS, Milan, Italy.\', \'Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0923-7534(20)42965-510.1016/j.annonc.2020.10.473
?:doi
?:hasPublicationType
?:journal
  • Annals of oncology : official journal of the European Society for Medical Oncology
is ?:pmid of
?:pmid
?:pmid
  • 33098994
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all